 - Planned administration of a vaccine not foreseen by the study protocol during the period starting 30 days before the first dose of study vaccineplacebo and ending at Month 4 It is recommended that the vaccination history of all subjects has been reviewed with their health care provider and that they have been encouraged to be fully vaccinated according to their country vaccination schedule for HIV- infected persons before enrolment into this study. 